MOL Magyar Olaj- és Gázipari Nyilvánosan Muködo Részvénytársaság (MOL)
Prague Stock Exchange · Czech Republic · prices in CZK · close of 23 Oct 2026
Key indicators
| Last close | CZK 323.00 |
|---|---|
| 52-week range | 49.52 – 355.40 |
| Return, 1 month / 3 months | −6.8% / +13.1% |
| Return, 1 year / 3 years | +85.3% / +99.9% |
| Trend | Uptrend |
| RSI (14) | 51 |
| Volatility (1 year) | 269.3% |
| Worst drawdown (1 year) | -85.4% |
| Average daily value traded | 0.02M CZK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MOL Magyar Olaj- és Gázipari Nyilvánosan Muködo Részvénytársaság, usually called MOL, is an integrated oil and gas group based in Budapest, Hungary. It explores for and produces crude oil and natural gas, refines fuels and petrochemicals, and runs a chain of filling stations serving motorists and commercial fleets across Central and Eastern Europe. The group also supplies wholesale fuel and petrochemical products to industrial customers, and its operations span upstream, downstream and petrochemical activities.
On this site MOL Magyar Olaj- és Gázipari Nyilvánosan Muködo Részvénytársaság appears as a stock on the Prague Stock Exchange (Czech Republic), code MOL, with prices in Czech koruna (CZK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MOL Magyar Olaj- és Gázipari Nyilvánosan Muködo Részvénytársaság (MOL) trades on the Prague Stock Exchange in Czech Republic. It last closed at CZK 323.00 on 23 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 24 of 45 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 85.3% and over the last three months it rose 13.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Prague Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.8% | ||
| From 52-week high | -9.1% | ||
| Momentum | 93 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.1% | ||
| 6-month return | 14.5% | ||
| 12-month return, skipping the last month | 98.7% | ||
| Stability (higher is calmer) | 1 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 269.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -85.4% | ||
| Liquidity | 16 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M CZK | ||
| Zero-volume days | 60.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | −6.8% |
| 3 months | +13.1% |
| 6 months | +14.5% |
| 1 year | +85.3% |
| 3 years | +99.9% |
| 5 years | +127.0% |
Signals
| 50-day / 200-day average | 310.25 / 269.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.16 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Prague Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.